首页> 外文期刊>BMC Musculoskeletal Disorders >Monobloc implants in cementless total hip arthroplasty in patients with Legg-Calve-Perthes disease: a long-term follow-up
【24h】

Monobloc implants in cementless total hip arthroplasty in patients with Legg-Calve-Perthes disease: a long-term follow-up

机译:Legg-Calve-Perthes病患者的非骨水泥全髋关节置换中的整体植入物:长期随访

获取原文
           

摘要

Background The purpose of this study was to evaluate 10-year outcomes in cementless monobloc total hip arthroplasty (THA) in a group of hips with Legg-Calve-Perthes disease (LCPD). Methods We reviewed 71 patients (88 hips) who underwent cementless THA with a diagnosis of LCPD from 2003 to 2009. From the total of 71 patients, 34 men and 37 women with an average age of 49.94?years were included. The mean follow-up period was 10 years. Results The mean Harris Hip Score improved significantly from 46.42 to 89.70. Similarly, the postoperative range of motion, hip dysfunction and osteoarthritis outcome score and SF-12 score also significantly improved. The mean leg lengthening was 22.1?mm. During the follow-up, eight complications were noted, including two cases of intraoperative femoral fractures, two cases of sciatic nerve paralysis, two cases of heterotrophic ossifications, one case of thigh pain and one case of dislocation. One revision was conducted for a periprosthetic fracture, and the survivorship at 10 years was 98.3%. Conclusions These data suggest that the monobloc stem can lead to satisfactory outcomes for clinical function, radiological evaluation, restoration of the normal limb lengths, complications, and survivorship among LCPD patients undergoing total hip arthroplasty.
机译:背景技术这项研究的目的是评估一组患有Legg-Calve-Perthes病(LCPD)的臀部的非骨水泥整体全髋关节置换术(THA)的10年结果。方法2003年至2009年,我们对71例行非骨水泥性THA并诊断为LCPD的患者(88髋)进行了回顾。在71例患者中,平均年龄为49.94岁的34例男性和37例女性包括在内。平均随访期为10年。结果Harris髋关节平均评分从46.42显着提高到89.70。同样,术后运动范围,髋关节功能障碍和骨关节炎预后评分以及SF-12评分也有明显改善。平均腿长为22.1?mm。随访期间,发现8处并发症,包括2例术中股骨骨折,2例坐骨神经麻痹,2例异养骨化,1例大腿疼痛和1例脱位。对假体周围骨折进行了一次修订,10年生存率为98.3%。结论这些数据表明,在进行全髋关节置换术的LCPD患者中,整体茎可以为临床功能,放射学评估,正常肢体长度的恢复,并发症和存活率带来令人满意的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号